Prescription weight-loss drugs: Can they help you? - Mayo Clinic
WEBOct 29, 2022 · Prescription weight-loss drugs that you can use for more than 12 weeks, called long-term use, lead to major weight loss compared with an inactive treatment that doesn't use medicine, called a placebo. The combination of weight-loss medicine and lifestyle changes leads to greater weight loss than do lifestyle changes alone.
GLP-1 agonists: Diabetes drugs and weight loss - Mayo Clinic
WEBJun 29, 2022 · These include canagliflozin (Invokana), ertugliflozin (Steglatro), dapagliflozin (Farxiga) and empagliflozin (Jardiance). Weight loss can vary depending on which GLP-1 drug you use and your dose. Studies have found that all GLP-1 drugs can lead to weight loss of about 10.5 to 15.8 pounds (4.8 to 7.2 kilograms, or kg) when using liraglutide.
Vitamin B-12 injections for weight loss: Do they work? - Mayo Clinic
WEBSep 13, 2022 · There's no solid proof that vitamin B-12 shots, also called injections, help you lose weight. Vitamin B-12 is a water-soluble B complex vitamin. It's found naturally in many foods, such as meat, fish and dairy products. Vitamin B-12 is added to some foods and is available as a dietary supplement. Health …
HCG diet: Is it safe and effective? - Mayo Clinic
WEBJun 4, 2024 · Answer From Katherine Zeratsky, R.D., L.D. No. The HCG diet isn't safe, and it doesn't lead to long-term weight loss. HCG stands for human chorionic gonadotropin. It's a hormone made in the body during pregnancy. Lab-made HCG is added to some weight-loss products that are sold without a prescription. The …
Weight-loss surgery: Is it an option for you? - Mayo Clinic
WEBOct 13, 2022 · BMI is a formula that uses weight and height to estimate body fat. Weight-loss surgery might be an option for an adult with a BMI of 40 or higher. The surgery may also be an option for an adult who meets these three conditions: BMI of 35 or higher. At least one obesity-related medical condition. At least six months of supervised weight-loss ...
Use of weight-loss pharmacotherapy in patients with cirrhosis and …
WEBAug 17, 2021 · In a review article published in Hepatology in 2021, Kymberly D. Watt, M.D., and co-authors discuss the use of four Food and Drug Administration (FDA)-approved weight-loss medications and three alternative medicine treatments in patients with cirrhosis and in liver transplant recipients.
Alli weight-loss pill: Does it work? - Mayo Clinic
WEBApr 9, 2024 · Alli is a 60-milligram, over-the-counter version of orlistat (Xenical), a 120-milligram prescription drug. Both Alli and Xenical are meant to be used as part of a weight-loss plan, along with a low-calorie, low-fat diet and regular physical activity. Alli is approved by the U.S. Food and Drug Administration for use in adults 18 and older who ...
Tirzepatide (Subcutaneous Route) Description and Brand Names
WEBIt is used together with diet and exercise to help control your blood sugar. Tirzapatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide injection is also used to help lose weight and keep the weight off in patients with obesity caused by certain conditions.
Semaglutide (Subcutaneous Route) Proper Use - Mayo Clinic
WEBAdults and children 12 years of age and older—At first, 0.25 milligrams (mg) injected under the skin once a week for 4 weeks. Your doctor may increase your dose every 4 weeks. However the dose is usually not more than 2.4 mg once a week. Children younger than 12 years of age—Use and dose must be determined by your doctor.
Insulin and weight gain: Keep the pounds off - Mayo Clinic
WEBThe link between insulin and weight gain. When you take insulin, sugar can enter your cells. This makes the sugar levels in your blood go down. This is the goal of treatment. But if you take in more calories than you need to keep a healthy weight, your cells will get more sugar than they need. This happens in people who don't have diabetes, too.